Follow The Filings

DSGN Design Therapeutics Inc.

Health Care, filed as DESIGN THERAPEUTICS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.3%
  • $1.5M
  • 1 new

In 2026 Q2 Nathan Fischel opened a position in Design Therapeutics.

Who owns this now

Largest portfolio weights among holders, up to 0.3% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.

  1. Nathan Fischel New 0.28%

Who owns DSGN

Sorted by value, long equity only, as of 2026 Q2.

History
Nathan Fischel, Dafna Capital Management 0.28% New 0.28% 102,600 $1.5M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc

Insider forms

Forms 3, 4 and 5 from EDGAR, 6 rows shown

Filed Form Detail Links
4 Period Jun 9, 2026 (6 forms) Filing Doc
4 Period Mar 31, 2026 Filing Doc
4 Period Jan 2, 2026 (5 forms) Filing Doc
4 Period Dec 9, 2025 Filing Doc
4 Period Sep 9, 2025 Filing Doc
4 Period Aug 13, 2025 Filing Doc

Source: SEC EDGAR submissions, updated 14 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$66.86M -$49.59M -$69.79M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $284.58M $248.04M $223.78M
Total non-current assets * $5.06M $4.05M $2.42M
Total assets $289.64M $252.09M $226.2M
Total current liabilities $9.62M $8.46M $13.06M
Total non-current liabilities * $2.33M $1.53M $0.645M
Total equity $277.69M $242.1M $212.5M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$58.56M -$43.1M -$54.36M
Cash from investing $52.54M $43.96M $22.91M
Cash from financing $0.724M $0.513M $25.74M
Net change in cash -$5.3M $1.36M -$5.71M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.